Noxap (Nitric Oxide)

Nitric Oxide, the active ingredient in Noxap, is a vasodilator presented as an inhalation gas for respiratory administration use. It is employed to manage conditions that benefit from pulmonary vasodilation, particularly in critical care settings. GNH USA supplies Noxap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Noxap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Noxap is administered through the respiratory pathway to support pulmonary vascular function.

- Pulmonary hypertension: Helps reduce vascular resistance in the lungs to improve oxygenation. - Acute respiratory distress syndrome (ARDS): Assists in optimising ventilation‑perfusion matching and oxygen delivery. - Peri‑operative cardiopulmonary support during cardiac surgery or transplant procedures :   -       -      -     -    

The ... ... ...  …  … ...